Nyxoah Highlights Early Findings from Neurostimulator Trial
Nyxoah will present data on the first 34 patients in the DREAM trial of its neurostimulator for sleep apnea at SLEEP 2023.
Stay updated with breaking news from Robert Taub. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nyxoah will present data on the first 34 patients in the DREAM trial of its neurostimulator for sleep apnea at SLEEP 2023.
REGULATED INFORMATIONNyxoah Reports First Quarter 2023 Financial and Operating Results Mont-Saint-Guibert, Belgium - May 16, 2023 10:05pm CET / 4:05pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)
Earth Alive tries to contribute to regenerative agriculture, natural dust suppression with minimal water use and industrial cleaning that is ecological and human friendly.
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces a $15 Million Private Placement Financing Mont-Saint-Guibert, Belgium - March 23, 2023, 9:05pm CET / 4:05pm ET - Nyxoah SA (Euronext
Investegate announcements from Nyxoah, Nyxoah Announces a $15 Million Private Placement Financing